1. Home
  2. MYO vs HOWL Comparison

MYO vs HOWL Comparison

Compare MYO & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$1.04

Market Cap

33.3M

Sector

Health Care

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.45

Market Cap

30.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYO
HOWL
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
30.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
MYO
HOWL
Price
$1.04
$0.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$7.67
$5.00
AVG Volume (30 Days)
335.5K
579.5K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.40
EPS
N/A
N/A
Revenue
$1,000,000,000.00
N/A
Revenue This Year
$9.10
N/A
Revenue Next Year
$13.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40814.79
N/A
52 Week Low
$0.61
$0.40
52 Week High
$3.22
$2.23

Technical Indicators

Market Signals
Indicator
MYO
HOWL
Relative Strength Index (RSI) 66.87 29.99
Support Level $0.90 N/A
Resistance Level $1.10 $0.75
Average True Range (ATR) 0.08 0.07
MACD 0.01 -0.02
Stochastic Oscillator 81.85 12.10

Price Performance

Historical Comparison
MYO
HOWL

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Share on Social Networks: